| 000 | 01802 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250514165816.0 | ||
| 264 | 0 | _c20040819 | |
| 008 | 200408s 0 0 eng d | ||
| 022 | _a1078-0432 | ||
| 024 | 7 |
_a10.1158/1078-0432.ccr-0689-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMitchell, Malcolm S | |
| 245 | 0 | 0 |
_aPhase I trial of large multivalent immunogen derived from melanoma lysates in patients with disseminated melanoma. _h[electronic resource] |
| 260 |
_bClinical cancer research : an official journal of the American Association for Cancer Research _cJan 2004 |
||
| 300 |
_a76-83 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase I; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdjuvants, Immunologic |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntigens, Neoplasm _ximmunology |
| 650 | 0 | 4 |
_aCancer Vaccines _ximmunology |
| 650 | 0 | 4 |
_aCell Membrane _ximmunology |
| 650 | 0 | 4 | _aCytotoxicity, Immunologic |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHLA-A2 Antigen _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aHypersensitivity, Delayed |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMelanoma _ximmunology |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 |
_aSilicon Dioxide _xchemistry |
| 650 | 0 | 4 |
_aT-Lymphocytes, Cytotoxic _ximmunology |
| 700 | 1 | _aKan-Mitchell, June | |
| 700 | 1 | _aMorrow, Philip R | |
| 700 | 1 | _aDarrah, Denise | |
| 700 | 1 | _aJones, Vicky E | |
| 700 | 1 | _aMescher, Matthew F | |
| 773 | 0 |
_tClinical cancer research : an official journal of the American Association for Cancer Research _gvol. 10 _gno. 1 Pt 1 _gp. 76-83 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1158/1078-0432.ccr-0689-3 _zAvailable from publisher's website |
| 999 |
_c14460164 _d14460164 |
||